BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22989830)

  • 1. Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
    Fujita Y; Tamada D; Kozawa J; Kobayashi Y; Sasaki S; Kitamura T; Yasuda T; Maeda N; Otsuki M; Okita K; Iwahashi H; Kaneto H; Funahashi T; Imagawa A; Shimomura I
    Intern Med; 2012; 51(18):2581-5. PubMed ID: 22989830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
    Hirose S; Iwahashi Y; Seo A; Sumiyoshi M; Takahashi T; Tamori Y
    Intern Med; 2016; 55(9):1137-42. PubMed ID: 27150868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using miglitol at 30 min before meal is effective in hyperinsulinemic hypoglycemia after a total gastrectomy.
    Shirakawa J; Murohashi Y; Okazaki N; Yamazaki S; Tamura T; Okuyama T; Togashi Y; Terauchi Y
    Endocr J; 2014; 61(11):1115-23. PubMed ID: 25142087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial Reactive Hypoglycemia Treated with a Low-dose Alpha-glucosidase Inhibitor: Voglibose May Suppress Oxidative Stress and Prevent Endothelial Dysfunction.
    Suzuki K; Katsura D; Sagara M; Aoki C; Nishida M; Aso Y
    Intern Med; 2016; 55(8):949-53. PubMed ID: 27086810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acarbose attenuates hypoglycemia from dumping syndrome in an elderly man with gastrectomy.
    Yamada M; Ohrui T; Asada M; Ishizawa K; Ebihara S; Arai H; Sasaki H
    J Am Geriatr Soc; 2005 Feb; 53(2):358-9. PubMed ID: 15673372
    [No Abstract]   [Full Text] [Related]  

  • 6. α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
    Shimabukuro M; Tanaka A; Sata M; Dai K; Shibata Y; Inoue Y; Ikenaga H; Kishimoto S; Ogasawara K; Takashima A; Niki T; Arasaki O; Oshiro K; Mori Y; Ishihara M; Node K;
    Cardiovasc Diabetol; 2017 Jul; 16(1):86. PubMed ID: 28683829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with alpha-glucosidase inhibitor for severe reactive hypoglycemia: a case report.
    Teno S; Nakajima-Uto Y; Nagai K; Shimizu-Saitoh M; Ozu H; Omori Y; Takizawa T
    Endocr J; 2000 Aug; 47(4):437-42. PubMed ID: 11075724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
    Hariya N; Mochizuki K; Inoue S; Saito M; Fuchigami M; Goda T; Osonoi T
    Drugs R D; 2014 Sep; 14(3):177-84. PubMed ID: 25079671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the alpha glucosidase inhibitor acarbose in patients with 'Middleton syndrome': normal gastric anatomy but with accelerated gastric emptying causing postprandial reactive hypoglycemia and diarrhea.
    Playford RJ; Pither C; Gao R; Middleton SJ
    Can J Gastroenterol; 2013 Jul; 27(7):403-4. PubMed ID: 23862171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumatosis cystoides intestinalis induced by the α-glucosidase inhibitor miglitol.
    Kojima K; Tsujimoto T; Fujii H; Morimoto T; Yoshioka S; Kato S; Yasuhara Y; Aizawa S; Sawai M; Makutani S; Yamamoto K; Mochi T; Fukui H
    Intern Med; 2010; 49(15):1545-8. PubMed ID: 20686288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
    Emoto T; Sawada T; Hashimoto M; Kageyama H; Terashita D; Mizoguchi T; Mizuguchi T; Motodi Y; Iwasaki M; Taira K; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
    Am J Cardiol; 2012 Jan; 109(1):42-6. PubMed ID: 21944671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
    Kimura T; Suzuki J; Ichikawa M; Imagawa M; Sato S; Fujii M; Zenimaru Y; Inaba S; Takahashi S; Konoshita T; Miyamori I
    Diabetes Technol Ther; 2012 Jul; 14(7):545-51. PubMed ID: 22519736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial reactive hypoglycemia in an oldest-old patient effectively treated with low-dose acarbose.
    Tamura Y; Araki A; Chiba Y; Horiuchi T; Mori S; Hosoi T
    Endocr J; 2006 Dec; 53(6):767-71. PubMed ID: 16966825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial hypoglycemia].
    Mori Y
    Nihon Rinsho; 2006 Sep; Suppl 3():224-9. PubMed ID: 17022536
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.
    Lee EY; Kaneko S; Jutabha P; Zhang X; Seino S; Jomori T; Anzai N; Miki T
    J Endocrinol; 2015 Mar; 224(3):205-14. PubMed ID: 25486965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
    Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
    Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven-day subcutaneous continuous glucose monitoring demonstrates that treatment with acarbose attenuates late dumping syndrome in a woman with gastrectomy for gastric cancer.
    Buscemi S; Mattina A; Genova G; Genova P; Nardi E; Costanzo M
    Diabetes Res Clin Pract; 2013 Jan; 99(1):e1-2. PubMed ID: 23146372
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment with acarbose for the treatment of reactive hypoglycemia.
    Ozgen AG; Hamulu F; Bayraktar F; Cetínkalp S; Yilmaz C; Túzún M; Kabalak T
    Eat Weight Disord; 1998 Sep; 3(3):136-40. PubMed ID: 10728163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.